FDA Inspection 1270829 — Ipsen Bioscience, Inc.

Ipsen Bioscience, Inc. — FEI 3008532848

The FDA completed an inspection of Ipsen Bioscience, Inc. on May 20, 2025 in Cambridge, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
May 20, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cambridge, MA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.